The total issue size of Beta Drugs IPO is up to ₹18.41 Cr whereas the issue size of the CMM Infraprojects IPO is up to ₹17.27 Cr. The final issue price of Beta Drugs IPO is ₹85.00 per share and of CMM Infraprojects IPO is ₹40.00 per share.
Beta Drugs IPO opens on Sep 29, 2017, while CMM Infraprojects IPO opens on Sep 29, 2017. The closing date of Beta Drugs IPO and CMM Infraprojects IPO is Oct 04, 2017, and Oct 04, 2017, respectively.
In the Beta Drugs IPO Retail Individual Investors (RII) are offered 10,83,200 shares while in CMM Infraprojects IPO retail investors are offered 10,83,200 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Beta Drugs IPO and 0 shares in CMM Infraprojects IPO.